SB202190对皮瓣缺血再灌注损伤时TNF-α和IL-10影响的实验研究
收稿日期: 2014-08-11
网络出版日期: 2014-12-04
基金资助
江苏省“333工程”培养资金资助项目（BRA2014091）
Experimental study on the influence of P38MAPK inhibitor SB202190 on cytokines in flap ischemic reperfusion injury
Received date: 2014-08-11
Online published: 2014-12-04
目的 探讨P38MAPK抑制剂SB202190对皮瓣缺血再灌注损伤发展及TNF-α与IL-10表达水平的影响。 方法 取12~14周龄健康Wistar大鼠48只，随机分为对照组（Ⅰ组）、缺血再灌注组（Ⅱ组）、生理盐水组（Ⅲ组）、P38抑制剂组（Ⅳ组），每组12只。制作大鼠腹部轴型皮瓣缺血再灌注损伤模型。术后7d，测定皮瓣存活率，检测大鼠血清TNF-α、IL-10浓度，切取皮瓣通过免疫组织化学方法检测P38MAPK与P-P38MAPK的表达。 结果 术后第7天，Ⅳ组皮瓣存活率显著高于Ⅱ、Ⅲ组（P <0.05），与Ⅰ组无统计学差异（P>0.05）。与Ⅱ、Ⅲ组相比，Ⅳ组P38MAPK与P-P38MAPK表达显著降低，血清TNF-α浓度明显降低，但IL-10浓度增高 (P<0. 05)。相关分析结果表明：皮瓣存活率与TNF-α浓度显著负相关，与IL-10浓度相关不显著。P38MAPK、P-P38MAPK评分与TNF-α浓度均显著正相关，与IL-10浓度相关不显著。 结论 SB202190可抑制皮瓣内P38MAPK信号通路，降低TNF-α浓度，减轻缺血再灌注损伤，提高皮瓣存活率。
关键词： 皮瓣; 缺血再灌注; SB202190; TNF-&alpha
吴建龙 , 巨积辉 , 周广良 , 金光哲 , 李志敏 , 侯瑞兴 . SB202190对皮瓣缺血再灌注损伤时TNF-α和IL-10影响的实验研究[J]. 中国临床解剖学杂志, 2014 , 32(6) : 698 -703 . DOI: 10.13418/j.issn.1001-165x.201
Objective To explore the P38 MAPK inhibitor SB202190 on IRI development and TNF-α、IL-10 expression levels in flap. Methods Forty-eight Wistar rats aged 12~14 weeks old, were randomly divided into control group (groupⅠ), ischemia-reperfusion group (groupⅡ), saline group (groupⅢ), P38 MAPK inhibitor group (groupⅣ). The superficial epigastric artery flap ischemia reperfusion injury model was made in the left lower quadrant abdominal of each rat. The flaps were harvested 7 days after injection to receive immunohistochemistry observation, and P38MAPK、P-P38MAPK scoring. The TNF-α and IL-10 levels of the superficial epigastric vein were tested. Results The survival rates of the flaps 7 days after operation in group Ⅳ was higher than in group Ⅱand Ⅲ significantly(P<0.05). The expression of P38MAPK and P-P38MAPK in groupⅣ was lower than that in groupⅡand Ⅲ. The expression of TNF-α in groupⅣ was lower than that in groupⅡand Ⅲ，but the IL-10 content in groupⅣ was higher than that in groupⅡ and Ⅲ. Pearson correlation analysis showed that there was a significant negative correlation between flap survival rates and TNF-α level; there was a significant positive correlation between P38MAPK, P-P38MAPK scoring and TNF-α level. Conclusion The intraperitoneal use of P38 MAPK inhibitor SB202190 can decrease of the plasma TNF-α level, and improve skin flap survival from the Ischemia- reperfusion injury by preventing the activation of P38MAPK pathway
Key words： Flap; Ischemia-reperfusion; SB202190; TNF-α
[1] Li L，Zhang YM，Qiao WL，et al. Role of mitogenactivated protein kinases in the regulation of paraventricular nucleus to gastric ischemia- reperfusion in juries
[J]. Chin Med J( Engl)，2007，120(12)：1082-1087.
[2] Uemura T，Tsujii M，Akeda K，et al.Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model
[J].J Gene Med，2012，14(11):623-631.
[3] Kobayashi M，Takeyoshi I，Yoshinari D，et al. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver
[J]. Surgery，2002，131( 3)：344-349.
[4] Grossi V，Liuzzi M，Murzilli S，et al. Sorafenib inhibits p38αactivity in colorectal cancer cells and synergizes with the DFG-in inhibitor SB202190 to increase apoptotic response
[J]. Cancer Biol Ther，2012，13(14)：1471-1481.
[5] Manson GF，Murphy GF，Anthenelli RM，et al. The role of oxygen-free radicals in ischemia tissue injury in island skin flaps
[J]. Ann Surg，1983，198(1)：87-90.
[6] 徐瑞生，葛建华，雷玉凯，等. 雌激素改善皮瓣再灌注损伤和血供的实验研究
[J]. 中国修复重建外科杂志，2009，23(8)：964-968.
[7] Kaptanoglu AF，Arca T，Sargon MF，et al. Protective effect of dexamethasone on fetal rat skin in experimental intrauterine ischaemia/reperfusion injury
[J]. Clin Exp Dermatol，2013，38(4)：396-402.
[8] Zhang C，Wu J，Xu X，et a1．Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury
[J].Basic Res Cardiol，2010，105(4)：453-464.
[9] Wang Y，Kawamura N，Schmelzer JD，et a1.Decreased peripheral nerve damage after ischemia-reperfusion injury in mice lacking TNF-αlpha
[J]. J Neurol Sci，2008，267(1-2)：107-111.
[10] 刘流，周海洋，冉珂，等．P38 MAPK信号通路在甘草酸二铵减轻兔心肌缺血再灌注损伤中的作用
[J]．南方医科大学学报，2010，30(2)：298-300.
[11]Zarubin T，Hart J．Activation and signaling of the P38 MAPkinase pathway
[J].Cell Res，2005，l5(1)：ll-l8．
[12]王雨，汤礼军，戴睿武，等. 离体肝脏早期缺血再灌注期间p38信号转导途径对TNF-α mRNA表达的影响
[J]．华西医学，2009，24(6)：1475-1479．
[13]王军，左其龙，徐汉荣，等. 大鼠局灶性脑缺血再灌注损伤时SB202190的保护作用
[J]. 南京医科大学学报(自然科学版)，2009，29 (6)：840-844.
[14]Uysal HY，Cuzdan SS，Kay?ran O，et al. Preventive effect of dexmedetomidine in ischemia-reperfusion injury
[J]. J Craniofac Surg，2012，23(5)：1287-1291.
[15] 王澍寰. 手外科学
[M]. 第3版. 北京：人民卫生出版社, 2011：457.
[16] Hiroshi N，Sanjiv M，Sheila SB，et al. Pathology of warm ischaemia and reperfusion injury in adipomusculocutaneous flap
[J]. Int J Exp Path，1993，74(1)：35-44.
/
| 〈 |
|
〉 |
京ICP备08002354号-3
